Home » Healthcare » Europe Addiction Treatment Market

Europe Addiction Treatment Market By Treatment Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Substances Addiction Treatment); By Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products, Others); By Treatment Center (Outpatient Treatment Centers, Residential Treatment Centers, Inpatient Treatment Centers); By Distribution Channel (Hospitals Pharmacies, Medical Stores, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
Europe Addiction Treatment Market Size 2023	USD 2,436.26 million
Europe Addiction Treatment Market, CAGR	5.89%
Europe Addiction Treatment Market Size 2032	USD 4,140.86 million

Market Overview

The Europe Addiction Treatment Market is projected to grow from USD 2,436.26 million in 2023 to an estimated USD 4,140.86 million by 2032, with a compound annual growth rate (CAGR) of 5.89% from 2024 to 2032. This growth is driven by increasing awareness of mental health issues, improved access to treatment facilities, and rising government initiatives to combat addiction.

Several factors drive this growth, including the increasing prevalence of substance abuse disorders and advancements in treatment methodologies. The integration of technology in treatment programs, such as telemedicine and mobile health applications, has enhanced the reach and effectiveness of addiction treatments. Additionally, a growing societal acceptance of seeking help for addiction problems and the destigmatization of mental health issues contribute to market expansion.

Geographically, Western Europe holds the largest market share, primarily due to the high availability of advanced healthcare infrastructure and supportive government policies. Key players in the market include prominent organizations such as Acadia Healthcare, Universal Health Services, and Pinnacle Treatment Centers. These companies are focused on expanding their services and improving treatment outcomes through innovative approaches and strategic partnerships, ensuring sustained growth in the Europe Addiction Treatment Market.

Market Drivers

Increasing Prevalence of Substance Abuse Disorders

The rising incidence of substance abuse disorders across Europe is a primary driver of the addiction treatment market. For instance, it was estimated that 5.5 percent of the global population between the ages of 15 and 64 years used an illicit drug in 2019. Substance abuse, encompassing alcohol, illicit drugs, and prescription medications, is becoming increasingly prevalent, impacting individuals and societies. According to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), millions of Europeans are affected by substance use disorders, necessitating comprehensive treatment and rehabilitation services. The increasing number of affected individuals has created a substantial demand for addiction treatment services, ranging from detoxification to long-term rehabilitation programs. Moreover, the complexity of substance abuse disorders, which often co-occur with mental health issues such as depression and anxiety, further intensifies the need for integrated treatment approaches. The dual diagnosis of mental health and addiction issues requires specialized care, prompting healthcare providers to develop and offer multifaceted treatment programs. This rising demand for comprehensive care drives the expansion and sophistication of addiction treatment facilities across Europe

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Advancements in Treatment Methodologies and Technologies

Innovations in treatment methodologies and the integration of advanced technologies have significantly contributed to the growth of the Europe addiction treatment market. Traditional treatment approaches, such as inpatient and outpatient rehabilitation programs, have evolved to incorporate evidence-based practices, ensuring more effective and personalized care for individuals battling addiction. The use of cognitive-behavioral therapy (CBT), motivational interviewing (MI), and other therapeutic techniques has proven effective in addressing the underlying causes of addiction and promoting long-term recovery. In addition to therapeutic advancements, technology has played a pivotal role in transforming addiction treatment. Telemedicine and mobile health applications have emerged as valuable tools in extending the reach of treatment services. These technologies enable healthcare providers to offer remote consultations, continuous monitoring, and real-time support to individuals undergoing treatment. Telemedicine, in particular, has gained traction in rural and underserved areas, where access to specialized addiction treatment services may be limited. For instance, despite a rapid increase in telemedicine visits for substance use disorder from 2010–2017, the overall use rates remain low. By leveraging technology, treatment providers can ensure that more individuals receive timely and effective care, thereby driving market growth.

Government Initiatives and Policy Support

Government initiatives and policy support have been instrumental in shaping the addiction treatment landscape in Europe. Recognizing the societal and economic impact of substance abuse, governments across Europe have implemented comprehensive strategies to combat addiction and promote recovery. These initiatives include increased funding for addiction treatment programs, public awareness campaigns, and the establishment of regulatory frameworks to ensure the quality and accessibility of treatment services. For instance, the European Union (EU) has adopted various policies aimed at reducing the harm caused by substance abuse and improving the availability of treatment services. The EU’s Action Plan on Drugs, which outlines strategic priorities and actions for addressing drug-related issues, emphasizes the importance of treatment and rehabilitation. National governments have also introduced measures to expand access to addiction treatment, such as subsidizing treatment costs and supporting the development of community-based services. These policy efforts create a conducive environment for the growth of the addiction treatment market, as they enhance the availability and affordability of treatment options for individuals in need.

Growing Societal Acceptance and Destigmatization of Addiction

Societal attitudes towards addiction and mental health have undergone a significant transformation in recent years, contributing to the growth of the addiction treatment market. Historically, addiction was often stigmatized, leading to social exclusion and reluctance among individuals to seek help. However, increasing public awareness and education about addiction as a medical condition have led to greater acceptance and understanding. Campaigns by non-governmental organizations (NGOs), healthcare providers, and advocacy groups have played a crucial role in destigmatizing addiction. These efforts emphasize that addiction is a treatable condition and encourage individuals to seek professional help without fear of judgment. As societal attitudes shift, more people are willing to pursue treatment, resulting in higher demand for addiction treatment services. This growing acceptance not only supports market expansion but also fosters a more supportive and inclusive environment for individuals undergoing treatment.

Market Trends

Integration of Digital Health Technologies

One of the most significant trends shaping the European Addiction Treatment Market is the integration of digital health technologies into treatment programs. The adoption of telemedicine, mobile health applications, and digital platforms has revolutionized the way addiction treatment services are delivered. Telemedicine, for instance, enables healthcare providers to offer remote consultations and continuous monitoring, making it easier for patients to access care regardless of their geographic location. This is particularly beneficial in rural and underserved areas where access to specialized addiction treatment services may be limited. According to the Substance Abuse and Mental Health Services Administration (SAMHSA), the percentage of mental health facilities offering telemedicine services increased from 38% in 2019 to 68.7% in 2021. The National Institute on Alcohol Abuse and Alcoholism (NIAAA) also highlights the promise of digital health technologies in addressing alcohol misuse among youth, with interventions like SafERteens showing reduced alcohol-related consequences and severe aggression in the year following the intervention.

Mobile health applications are also gaining popularity, offering a range of functionalities such as virtual therapy sessions, appointment scheduling, medication reminders, and real-time support. These apps provide patients with convenient tools to manage their recovery, stay connected with their healthcare providers, and track their progress. The use of digital platforms allows for the collection and analysis of patient data, enabling personalized treatment plans and improving overall treatment outcomes. The COVID-19 pandemic has accelerated the adoption of these technologies, as restrictions on in-person interactions have highlighted the need for remote care solutions. This trend is expected to continue, driving innovation and improving accessibility in the addiction treatment market.

Emphasis on Holistic and Integrated Treatment Approaches

Another notable trend in the European addiction treatment market is the growing emphasis on holistic and integrated treatment approaches. Traditional addiction treatment is often focused primarily on detoxification and abstinence. However, there is an increasing recognition that successful addiction treatment must address the comprehensive needs of the individual, including physical, psychological, and social aspects. A study found that around 85% of therapists draw on multiple therapeutic traditions in their treatment, demonstrating the appeal of holistic approaches. This holistic approach involves integrating various therapeutic modalities to provide a more rounded and effective treatment experience.

Treatment programs are increasingly incorporating mental health services, recognizing the high comorbidity between addiction and mental health disorders such as depression, anxiety, and PTSD. By addressing these co-occurring disorders concurrently, treatment providers can improve patient outcomes and reduce the risk of relapse. Additionally, there is a growing focus on incorporating complementary therapies such as mindfulness, yoga, nutrition counseling, and exercise programs into addiction treatment plans. These therapies support overall well-being and help individuals develop healthy coping mechanisms.

Family involvement is also becoming a crucial component of addiction treatment, as supportive family dynamics can significantly enhance recovery outcomes. Family therapy sessions and educational programs help families understand addiction, improve communication, and provide a supportive environment for the individual in recovery. The emphasis on holistic and integrated treatment approaches reflects a broader understanding of addiction as a multifaceted condition necessitating comprehensive and personalized care strategies. This trend is likely to persist, driving the development of more effective and patient-centered addiction treatment programs in Europe.

Market Restraints and Challenges

Limited Access to Treatment Facilities

One of the primary challenges facing the Europe Addiction Treatment Market is the limited access to treatment facilities. Despite the growing recognition of addiction as a significant public health issue, many regions, particularly rural and underserved areas, lack adequate addiction treatment infrastructure. This geographical disparity means that individuals in need of treatment often have to travel long distances to access specialized services, which can be a significant barrier to seeking help. Additionally, the availability of treatment facilities is often constrained by funding limitations. Public healthcare systems across Europe are under significant financial strain, and addiction treatment services frequently compete for resources with other critical healthcare needs. This competition can result in insufficient funding for addiction treatment programs, leading to long waiting times and reduced capacity to accept new patients. The lack of accessible and adequately funded treatment facilities impedes the ability of individuals to receive timely and effective care, posing a significant challenge to the market’s growth.

Stigma and Societal Barriers

Stigma and societal barriers continue to be substantial restraints in the Europe Addiction Treatment Market. Despite progress in public awareness and acceptance, addiction remains highly stigmatized, which can deter individuals from seeking treatment. The fear of judgment, discrimination, and social exclusion can prevent people from acknowledging their addiction and accessing the help they need. This stigma is particularly pronounced in certain cultures and communities where addiction is viewed as a moral failing rather than a medical condition. Furthermore, societal attitudes towards addiction can influence policy and funding decisions, often leading to insufficient support for addiction treatment services. The stigma associated with addiction can result in a lack of political will to prioritize addiction treatment, affecting the allocation of resources and the development of supportive policies. Moreover, healthcare professionals themselves can sometimes hold stigmatizing attitudes, which can impact the quality of care provided to individuals with addiction. Addressing these societal barriers requires ongoing public education, advocacy, and efforts to reshape perceptions of addiction as a treatable medical condition. Overcoming these challenges is essential to improving access to and the effectiveness of addiction treatment services in Europe.

Market Segmentation Analysis

By Treatment Type

The Europe addiction treatment market comprises several significant segments, including alcohol, tobacco/nicotine, opioid, and other substances addiction treatments. Alcohol addiction treatment is driven by the rising prevalence of alcohol use disorders and increased awareness of its harmful effects, incorporating therapies like behavioral counseling, detoxification, and medication-assisted treatment for long-term recovery. Tobacco/nicotine addiction treatment has grown through public health campaigns and smoking cessation programs, utilizing nicotine replacement therapies, prescription medications, and behavioral therapies. The opioid addiction treatment segment is rapidly expanding due to the ongoing opioid crisis, offering medication-assisted treatments (MAT) such as methadone, buprenorphine, and naltrexone, along with counseling services. Additionally, treatments for addictions to substances like cannabis, stimulants, and sedatives are in demand, addressing the specific challenges of each substance use disorder.

By Drug Type

In the Europe Addiction Treatment Market, several key medications are utilized to address various substance use disorders. Bupropion and Varenicline are essential in smoking cessation programs, reducing nicotine cravings and withdrawal symptoms, with Varenicline also decreasing the pleasure associated with smoking. Acamprosate and Disulfiram are pivotal in alcohol addiction treatment; Acamprosate helps maintain abstinence by reducing cravings, while Disulfiram deters alcohol consumption by causing unpleasant reactions. Naltrexone is versatile, used in both alcohol and opioid addiction treatments to block euphoric effects and reduce substance desire. Methadone and Buprenorphine, crucial in medication-assisted treatment (MAT) for opioid addiction, manage withdrawal symptoms and cravings, with Buprenorphine offering a safer profile. Nicotine replacement products, like patches and gums, are also widely used to control nicotine intake and alleviate withdrawal. Additionally, other medications tailored to specific addiction needs further enhance treatment efficacy.

Segments

Based on Treatment Type

Alcohol Addiction Treatment
Tobacco/Nicotine Addiction Treatment
Opioid Addiction Treatment
Other Substances Addiction Treatment

Based on Drug Type

Bupropion
Varenicline
Acamprosate
Disulfiram
Naltrexone
Methadone
Buprenorphine
Nicotine Replacement Products
Others

Based on Treatment Center

Outpatient Treatment Centers
Residential Treatment Centers
Inpatient Treatment Centers

Based on Distribution Channel

Hospitals Pharmacies
Medical Stores
Others

Based on Region

Western Europe
Northern Europe
Southern Europe
Eastern Europe

Regional Analysis

Western Europe (45%):

Western Europe holds the largest market share in the Europe addiction treatment market, accounting for approximately 45% of the overall market. This region’s dominance can be attributed to several factors, including the presence of advanced healthcare infrastructure, high healthcare expenditure, and strong government initiatives aimed at addressing substance abuse. Countries like Germany, France, and the United Kingdom are at the forefront, offering comprehensive treatment programs and well-established rehabilitation centers. The availability of a wide range of treatment options, from inpatient and outpatient services to specialized therapy and medication-assisted treatments, ensures that individuals receive tailored care suited to their specific needs.

Northern Europe (25%):

Northern Europe accounts for around 25% of the Europe addiction treatment market. This region is characterized by a robust public health system and proactive government policies that support addiction treatment and recovery. Countries such as Sweden, Norway, and Denmark have implemented extensive harm reduction strategies and public awareness campaigns to combat substance abuse. The integration of digital health technologies, such as telemedicine and mobile health apps, has further enhanced access to treatment services, particularly in remote and underserved areas. The emphasis on holistic and patient-centered approaches in addiction treatment programs also contributes to the market’s growth in Northern Europe.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key players

Teva Pharmaceutical Industries Ltd.
Pfizer, Inc.
Alkermes Plc.
Glenmark Pharmaceuticals
GSK plc
Johnson & Johnson Services, Inc.
Novartis AG
Perrigo Company plc
Cipla
Reddy’s Laboratories Limited
Hikma Pharmaceuticals Plc.
Indivior Inc.
Mylan N.V.
Eli Lilly and Company
Camurus AB

Competitive Analysis

The Europe addiction treatment market is characterized by intense competition among key players striving to enhance their market presence and treatment offerings. Companies like Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and Johnson & Johnson Services, Inc. lead the market through their extensive portfolios of addiction treatment medications and therapies. These companies invest significantly in research and development to innovate and improve treatment efficacy. Indivior Inc. and Alkermes Plc. focus on specialized addiction treatments, particularly in opioid dependency, leveraging their expertise to capture significant market share. Novartis AG and GSK plc contribute through their robust distribution networks and strong brand recognition. Smaller players like Camurus AB and Glenmark Pharmaceuticals are also making strides by introducing novel treatment solutions. The competitive landscape is further intensified by strategic collaborations, mergers, and acquisitions aimed at expanding market reach and enhancing service capabilities. This dynamic environment drives continuous advancements and improvements in addiction treatment options available in Europe.

Recent Developments

In June 2021, AELIS FARMA, a biotechnology company specializing in brain disorder treatments, announced a strategic partnership and option license agreement with INDIVIOR PLC. This collaboration aims to address severe consequences of cannabis use disorders (CUD), including cannabis-induced psychosis (CIP).

In June 2021, Terveystalo Healthcare acquired a 72% shareholding in Feelgood Svenska AB. The acquisition included a recommended mandatory offer of SEK 5.7 per share, strengthening Terveystalo’s position in the healthcare market.

In June 2021, The Ridge announced the opening of a new facility dedicated to providing exclusive private treatment for individuals suffering from drug and alcohol addiction. This new center aims to offer specialized care and support to those in need.

On May 14, 2024, Lifespan Health System launched a new addiction treatment program called Addiction Care Today. This initiative offers walk-in and same-day appointments for individuals seeking immediate help for substance use disorders, aiming to provide timely and accessible care.

On February 9, 2024, the Union Council of Ministers announced the opening of 41 addiction treatment facilities in Delhi. These centers will provide free treatment, counseling, and medications to individuals struggling with substance addiction, aiming to improve access to essential services.

In May 2023, Camurus AB, a Swedish biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Brixadi (buprenorphine) extended-release injection for subcutaneous use. This medication is intended to treat moderate to severe opioid use disorder (OUD), offering a new option for patients seeking treatment.

Market Concentration and Characteristics

The Europe Addiction Treatment Market is characterized by a moderate to high market concentration, with several key players dominating the industry. Major pharmaceutical companies such as Teva Pharmaceutical Industries Ltd., Pfizer, Inc., and Johnson & Johnson Services, Inc., hold significant market shares due to their extensive product portfolios and robust research and development capabilities. The market is distinguished by its diverse range of treatment options, including medication-assisted treatments (MAT), behavioral therapies, and digital health solutions. There is a strong emphasis on innovation and the integration of advanced technologies to enhance treatment efficacy and accessibility. Additionally, the market is supported by substantial government initiatives and policies aimed at reducing substance abuse and improving public health outcomes. The competitive landscape is dynamic, with ongoing mergers, acquisitions, and strategic collaborations shaping the market’s evolution.

Report Coverage

The research report offers an in-depth analysis based on Treatment Type, Drug Type, Treatment Center, Distribution Channel and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

Governments across Europe are expected to increase funding for addiction treatment programs, enhancing the availability and quality of services.

The adoption of telemedicine will continue to grow, providing remote access to treatment services and reducing barriers for individuals in rural and underserved areas.

Innovations in medication-assisted treatments (MAT) will lead to more effective and personalized therapies, improving recovery rates for patients with substance use disorders.

The incorporation of holistic and complementary therapies, such as mindfulness and nutrition counseling, will become more prevalent, addressing the comprehensive needs of patients.

Outpatient treatment services are anticipated to expand, offering flexible and cost-effective options for individuals seeking addiction treatment while maintaining their daily routines.

There will be a stronger emphasis on addressing co-occurring mental health disorders in addiction treatment, ensuring integrated care for better patient outcomes.

Increased public awareness campaigns will continue to destigmatize addiction, encouraging more individuals to seek help and support for their substance use disorders.

The use of artificial intelligence and data analytics in addiction treatment will enhance patient monitoring, treatment personalization, and outcome prediction.

Strategic collaborations between healthcare providers, pharmaceutical companies, and non-governmental organizations will drive the development and dissemination of effective treatment modalities.

Supportive regulatory frameworks will facilitate the approval and implementation of new treatment methods and medications, accelerating the adoption of advanced addiction treatment solutions.

CHAPTER NO. 1 : INTRODUCTION 15

1.1.1. Report Description 15

Purpose of the Report 15

USP & Key Offerings 15

1.1.2. Key Benefits for Stakeholders 15

1.1.3. Target Audience 16

1.1.4. Report Scope 16

CHAPTER NO. 2 : EXECUTIVE SUMMARY 17

2.1. Europe Addiction Treatment Market Snapshot 17

2.1.1. Europe Addiction Treatment Market, 2018 – 2032 (USD Million) 18

CHAPTER NO. 3 : EUROPE ADDICTION TREATMENT MARKET – INDUSTRY ANALYSIS 19

3.1. Introduction 19

3.2. Market Drivers 20

3.2.1. Driving Factor 1 Analysis 20

3.2.2. Driving Factor 2 Analysis 21

3.3. Market Restraints 22

3.3.1. Restraining Factor Analysis 22

3.4. Market Opportunities 23

3.4.1. Market Opportunity Analysis 23

3.5. Porter’s Five Forces Analysis 24

CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE 25

4.1. Company Market Share Analysis – 2023 25

4.1.1. Europe Addiction Treatment Market: Company Market Share, by Volume, 2023 25

4.1.2. Europe Addiction Treatment Market: Company Market Share, by Revenue, 2023 26

4.1.3. Europe Addiction Treatment Market: Top 6 Company Market Share, by Revenue, 2023 26

4.1.4. Europe Addiction Treatment Market: Top 3 Company Market Share, by Revenue, 2023 27

4.2. Europe Addiction Treatment Market Company Revenue Market Share, 2023 28

4.3. Company Assessment Metrics, 2023 29

4.3.1. Stars 29

4.3.2. Emerging Leaders 29

4.3.3. Pervasive Players 29

4.3.4. Participants 29

4.4. Start-ups /SMEs Assessment Metrics, 2023 29

4.4.1. Progressive Companies 29

4.4.2. Responsive Companies 29

4.4.3. Dynamic Companies 29

4.4.4. Starting Blocks 29

4.5. Strategic Developments 30

4.5.1. Acquisitions & Mergers 30

New Product Launch 30

Europe Expansion 30

4.6. Key Players Product Matrix 31

CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS 32

5.1. PESTEL 32

5.1.1. Political Factors 32

5.1.2. Economic Factors 32

5.1.3. Social Factors 32

5.1.4. Technological Factors 32

5.1.5. Environmental Factors 32

5.1.6. Legal Factors 32

5.2. Adjacent Market Analysis 32

CHAPTER NO. 6 : EUROPE ADDICTION TREATMENT MARKET – BY TREATMENT TYPE SEGMENT ANALYSIS 33

6.1. Europe Addiction Treatment Market Overview, by Treatment Type Segment 33

6.1.1. Europe Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 34

6.1.2. Europe Addiction Treatment Market Attractiveness Analysis, By Treatment Type 35

6.1.3. Incremental Revenue Growth Opportunity, by Treatment Type, 2024 – 2032 35

6.1.4. Europe Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 36

6.2. Alcohol Addiction Treatment 37

6.3. Tobacco/Nicotine Addiction Treatment 38

6.4. Opioid Addiction Treatment 39

6.5. Other Substances Addiction Treatment 40

CHAPTER NO. 7 : EUROPE ADDICTION TREATMENT MARKET – BY DRUG TYPE SEGMENT ANALYSIS 41

7.1. Europe Addiction Treatment Market Overview, by Drug Type Segment 41

7.1.1. Europe Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 42

7.1.2. Europe Addiction Treatment Market Attractiveness Analysis, By Drug Type 43

7.1.3. Incremental Revenue Growth Opportunity, by Drug Type, 2024 – 2032 43

7.1.4. Europe Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 44

7.2. Bupropion 45

7.3. Varenicline 46

7.4. Acamprosate 47

7.5. Disulfiram 48

7.6. Naltrexone 49

7.7. Methadone 49

7.8. Buprenorphine 50

7.9. Nicotine Replacement Products 50

7.10. Others 51

CHAPTER NO. 8 : EUROPE ADDICTION TREATMENT MARKET – BY TREATMENT CENTER SEGMENT ANALYSIS 52

8.1. Europe Addiction Treatment Market Overview, by Treatment Centre Segment 52

8.1.1. Europe Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 53

8.1.2. Europe Addiction Treatment Market Attractiveness Analysis, By Treatment Center 54

8.1.3. Incremental Revenue Growth Opportunity, by Treatment Center, 2024 – 2032 54

8.1.4. Europe Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 55

8.2. Outpatient Treatment Centers 56

8.3. Residential Treatment Centers 57

8.4. Inpatient Treatment Centers 58

CHAPTER NO. 9 : EUROPE ADDICTION TREATMENT MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 59

9.1. Europe Addiction Treatment Market Overview, by Distribution Channel Segment 59

9.1.1. Europe Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 60

9.1.2. Europe Addiction Treatment Market Attractiveness Analysis, By Distribution Channel 61

9.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 61

9.1.4. Europe Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 62

9.2. Hospitals Pharmacies 63

9.3. Medical Stores 64

9.4. Others 65

CHAPTER NO. 10 : ADDICTION TREATMENT MARKET – EUROPE 66

10.1. Europe 66

10.1.1. Key Highlights 66

10.1.2. Europe Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 67

10.1.3. Europe Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 68

10.1.4. Europe Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 69

10.1.5. Europe Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 70

10.1.6. Europe Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 71

10.2. UK 72

10.3. France 72

10.4. Germany 72

10.5. Italy 72

10.6. Spain 72

10.7. Russia 72

10.8. Belgium 72

10.9. Netherland 72

10.10. Austria 72

10.11. Sweden 72

10.12. Poland 72

10.13. Denmark 72

10.14. Switzerland 72

10.15. Rest of Europe 72

CHAPTER NO. 12 : COMPANY PROFILES 73

12.1. Teva Pharmaceutical Industries Ltd. 73

12.1.1. Company Overview 73

12.1.2. Product Portfolio 73

12.1.3. Swot Analysis 73

12.1.4. Business Strategy 74

12.1.5. Financial Overview 74

12.2. Pfizer, Inc. 75

12.3. Alkremes Plc. 75

12.4. Glenmark Pharmaceuticals 75

12.5. GSK plc 75

12.6. Johnson & Johnson Services, Inc. 75

12.7. Novartis AG 75

12.8. Perrigo Company plc. 75

12.9. Cipla 75

12.10. Dr. Reddy’s Laboratories Limited 75

12.11. Hikma Pharmaceuticals Plc. 75

12.12. Indivior Inc. 75

12.13. Mylan N.V. 75

12.14. Eli Lilly and Company 75

12.15. Camurus AB 75

CHAPTER NO. 13 : RESEARCH METHODOLOGY 76

13.1. Research Methodology 76

13.1.1. Phase I – Secondary Research 77

13.1.2. Phase II – Data Modeling 77

Company Share Analysis Model 78

Revenue Based Modeling 78

13.1.3. Phase III – Primary Research 79

13.1.4. Research Limitations 80

Assumptions 80

List of Figures

FIG NO. 1. Europe Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 18

FIG NO. 2. Porter’s Five Forces Analysis for Europe Addiction Treatment Market 24

FIG NO. 3. Company Share Analysis, 2023 25

FIG NO. 4. Company Share Analysis, 2023 26

FIG NO. 5. Company Share Analysis, 2023 26

FIG NO. 6. Company Share Analysis, 2023 27

FIG NO. 7. Europe Addiction Treatment Market – Company Revenue Market Share, 2023 28

FIG NO. 8. Europe Addiction Treatment Market Revenue Share, By Treatment Type, 2023 & 2032 34

FIG NO. 9. Market Attractiveness Analysis, By Treatment Type 35

FIG NO. 10. Incremental Revenue Growth Opportunity by Treatment Type, 2024 – 2032 35

FIG NO. 11. Europe Addiction Treatment Market Revenue, By Treatment Type, 2018, 2023, 2027 & 2032 36

FIG NO. 12. Europe Addiction Treatment Market for Alcohol Addiction Treatment, Revenue (USD Million) 2018 – 2032 37

FIG NO. 13. Europe Addiction Treatment Market for Tobacco/Nicotine Addiction Treatment, Revenue (USD Million) 2018 – 2032 38

FIG NO. 14. Europe Addiction Treatment Market for Opioid Addiction Treatment, Revenue (USD Million) 2018 – 2032 39

FIG NO. 15. Europe Addiction Treatment Market for Other Substances Addiction Treatment, Revenue (USD Million) 2018 – 2032 40

FIG NO. 16. Europe Addiction Treatment Market Revenue Share, By Drug Type, 2023 & 2032 42

FIG NO. 17. Market Attractiveness Analysis, By Drug Type 43

FIG NO. 18. Incremental Revenue Growth Opportunity by Drug Type, 2024 – 2032 43

FIG NO. 19. Europe Addiction Treatment Market Revenue, By Drug Type, 2018, 2023, 2027 & 2032 44

FIG NO. 20. Europe Addiction Treatment Market for Bupropion, Revenue (USD Million) 2018 – 2032 45

FIG NO. 21. Europe Addiction Treatment Market for Varenicline, Revenue (USD Million) 2018 – 2032 46

FIG NO. 22. Europe Addiction Treatment Market for Acamprosate, Revenue (USD Million) 2018 – 2032 47

FIG NO. 23. Europe Addiction Treatment Market for Disulfiram, Revenue (USD Million) 2018 – 2032 48

FIG NO. 24. Europe Addiction Treatment Market for Naltrexone, Revenue (USD Million) 2018 – 2032 49

FIG NO. 25. Europe Addiction Treatment Market for Methadone, Revenue (USD Million) 2018 – 2032 49

FIG NO. 26. Europe Addiction Treatment Market for Buprenorphine, Revenue (USD Million) 2018 – 2032 50

FIG NO. 27. Europe Addiction Treatment Market for Nicotine Replacement Products, Revenue (USD Million) 2018 – 2032 50

FIG NO. 28. Europe Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 51

FIG NO. 29. Europe Addiction Treatment Market Revenue Share, By Treatment Center, 2023 & 2032 53

FIG NO. 30. Market Attractiveness Analysis, By Treatment Center 54

FIG NO. 31. Incremental Revenue Growth Opportunity by Treatment Center, 2024 – 2032 54

FIG NO. 32. Europe Addiction Treatment Market Revenue, By Treatment Center, 2018, 2023, 2027 & 2032 55

FIG NO. 33. Europe Addiction Treatment Market for Outpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 56

FIG NO. 34. Europe Addiction Treatment Market for Residential Treatment Centers, Revenue (USD Million) 2018 – 2032 57

FIG NO. 35. Europe Addiction Treatment Market for Inpatient Treatment Centers, Revenue (USD Million) 2018 – 2032 58

FIG NO. 36. Europe Addiction Treatment Market Revenue Share, By Distribution Channel, 2023 & 2032 60

FIG NO. 37. Market Attractiveness Analysis, By Distribution Channel 61

FIG NO. 38. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 61

FIG NO. 39. Europe Addiction Treatment Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 62

FIG NO. 40. Europe Addiction Treatment Market for Hospitals Pharmacies, Revenue (USD Million) 2018 – 2032 63

FIG NO. 41. Europe Addiction Treatment Market for Medical Stores, Revenue (USD Million) 2018 – 2032 64

FIG NO. 42. Europe Addiction Treatment Market for Others, Revenue (USD Million) 2018 – 2032 65

FIG NO. 43. Europe Addiction Treatment Market Revenue, 2018 – 2032 (USD Million) 66

FIG NO. 44. Research Methodology – Detailed View 76

FIG NO. 45. Research Methodology 77

List of Tables

TABLE NO. 1. : Europe Addiction Treatment Market: Snapshot 17

TABLE NO. 2. : Drivers for the Europe Addiction Treatment Market: Impact Analysis 20

TABLE NO. 3. : Restraints for the Europe Addiction Treatment Market: Impact Analysis 22

TABLE NO. 4. : Europe Addiction Treatment Market Revenue, By Country, 2018 – 2023 (USD Million) 67

TABLE NO. 5. : Europe Addiction Treatment Market Revenue, By Country, 2024 – 2032 (USD Million) 67

TABLE NO. 6. : Europe Addiction Treatment Market Revenue, By Treatment Type, 2018 – 2023 (USD Million) 68

TABLE NO. 7. : Europe Addiction Treatment Market Revenue, By Treatment Type, 2024 – 2032 (USD Million) 68

TABLE NO. 8. : Europe Addiction Treatment Market Revenue, By Drug Type, 2018 – 2023 (USD Million) 69

TABLE NO. 9. : Europe Addiction Treatment Market Revenue, By Drug Type, 2024 – 2032 (USD Million) 69

TABLE NO. 10. : Europe Addiction Treatment Market Revenue, By Treatment Center, 2018 – 2023 (USD Million) 70

TABLE NO. 11. : Europe Addiction Treatment Market Revenue, By Treatment Center, 2024 – 2032 (USD Million) 70

TABLE NO. 12. : Europe Addiction Treatment Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 71

TABLE NO. 13. : Europe Addiction Treatment Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 71

Frequently Asked Questions:

What is the projected growth of the Europe Addiction Treatment Market?

The Europe Addiction Treatment Market is projected to grow from USD 2,436.26 million in 2023 to USD 4,140.86 million by 2032, with a CAGR of 5.89% from 2024 to 2032.

What factors are driving the growth of the addiction treatment market in Europe?

The market growth is driven by increasing awareness of mental health issues, improved access to treatment facilities, and rising government initiatives to combat addiction.

How is technology influencing addiction treatment in Europe?

Technology, including telemedicine and mobile health applications, is enhancing the reach and effectiveness of addiction treatments by enabling remote consultations and continuous patient support.

What role do government initiatives play in the addiction treatment market?

Government initiatives provide essential support through funding, public awareness campaigns, and regulatory frameworks, improving the availability and quality of addiction treatment services.

Who are some of the key players in the Europe Addiction Treatment Market?

Key players include Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Alkermes Plc., Glenmark Pharmaceuticals, GSK plc, Johnson & Johnson Services, Inc., and Novartis AG.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –